BRD2 and breast cancer: In recent years, an increasing body of evidence supports that high levels of postmenopausal FSH and luteinizing hormone are risk factors for BC.[32] It can be hypothesized that the expression of FSH-related genes in AFS indirectly promotes estrogen secretion by increasing FSH levels, thus leading to the development of BC.